Quick answer
When a father is diagnosed with prostate cancer, the family helps a lot by understanding the report, going to the consultation and supporting the recovery. The first step is to know the risk group, which combines the ISUP grade from the biopsy, the PSA and the digital rectal exam.1 It guides the choice between active surveillance, surgery and radiotherapy, and in most cases there is time to decide calmly.2,10 In my practice, the consultation can be in person or online, there is time for the questions of whoever comes along, and a son can join the consultation online from another city or country. Sons should also think about their own PSA: I recommend starting at 40.
The family's role
Often the person searching about the cancer is the son, the daughter or the wife. Families commonly help gather the tests, book the appointments, think about the cost and plan the trip when treatment is in another city or country.
The American guideline asks that the treatment choice be shared with the patient, weighing the risk of the cancer and the effects of each option on urination, erections and the bowel.3 The family can help put those priorities into words, and the decision remains his.
Understanding the report and the risk group
The biopsy report gives the Gleason score and the ISUP grade group, how many cores had cancer and how much of each core was involved. The page on Gleason, ISUP and the biopsy report explains each grade.
With the ISUP grade, the PSA and the rectal exam, the European guideline divides prostate cancer into risk groups:1
| Group | How it is defined |
|---|---|
| Low risk | ISUP 1, PSA below 10 ng/mL and tumor confined to the prostate on the rectal exam |
| Intermediate risk | ISUP 2 or 3, or PSA between 10 and 20 ng/mL, with tumor confined to the prostate on the rectal exam |
| High risk | ISUP 4 or 5, or PSA above 20 ng/mL |
| Locally advanced | Tumor beyond the prostate on the rectal exam (cT3 or cT4) or suspicious lymph nodes on imaging, with any ISUP and any PSA |
The risk group calculator works this out with the data from your father's report. Each group has its own page: low risk, intermediate risk, high risk and locally advanced. The first steps after the diagnosis are in just diagnosed: what now?.
The treatment options
With the risk group and the tests, the conversation moves to treatment. In my practice, I assess each case individually, by the risk group, the man's health and what matters most to him.
- Active surveillance: monitoring with PSA, MRI and repeat biopsies, and treating if the tumor changes. It is the standard approach for low risk in the European guideline.2 In low risk, I assess each case individually. Personally, I do not recommend active surveillance in intermediate risk, not even in the favorable group, although the European guideline accepts it in carefully selected ISUP 2 cases.2
- Robotic radical prostatectomy: removal of the prostate and seminal vesicles. The European guideline offers it in intermediate risk and, in selected patients, in high risk.2
- Radiotherapy: in intermediate risk, it comes with 4 to 6 months of hormone therapy, and in high risk, with 2 to 3 years.2
The page surgery or radiotherapy compares the two. When I recommend surgery in intermediate or high risk, I advise operating as soon as possible, without hormone therapy while the patient waits. In a review of 19 studies, waiting about 3 months generally did not worsen surgical outcomes, which leaves time for tests and a second opinion.10 Between the biopsy and the prostatectomy, I usually wait 4 weeks, as I explain in time between biopsy and surgery.
What about my father's age?
It is one of the questions children ask most. The European guideline uses a life expectancy of more than 10 years as the threshold for local treatment to bring benefit, and asks that health, frailty and other diseases weigh more than age. Above 70, the assessment starts with a short questionnaire, the G8.2
The page age and prostate surgery covers the studies in older men. Before major surgery, I always ask for a cardiology assessment.
How to join the consultation
Going along to the consultation helps you remember what was said and ask the questions that were left behind. In the consultation, there is time for his questions and those of whoever comes with him.
Any consultation can be online, by video on Google Meet. A second opinion can also be fully online, with the tests sent beforehand, and we start from the tests he already has. If you live in another city or country, you can join the consultation online from wherever you are. Just arrange it with the office on WhatsApp. The online consultation page explains the steps.
What to bring:
- The biopsy report, with the Gleason score, the ISUP grade group and the cores with cancer
- The MRI report and images
- Every PSA result, with dates
- Other imaging, such as a PSMA PET, if already done
- The list of his medications, other diseases and previous surgeries
Questions that usually help:
- What is the risk group, and what led to it?
- Is any test missing before deciding?
- Is active surveillance an option in this case?
- What can surgery and radiotherapy change in urination, erections and the bowel?
- What will follow-up look like after treatment?
If surgery is the path, the page questions before prostatectomy lists what is worth asking the surgeon.
Cost and insurance
In Brazil, robot-assisted radical prostatectomy has been on the list of procedures health plans must cover (ANS) since April 2026, for localized or locally advanced prostate cancer. In my practice, the plan covers the hospital stay and materials, and the team's fees are private. For patients from abroad, payment can be in Brazilian reais or in US dollars. If surgery is recommended, the quote comes in less than 24 hours after the consultation and is valid for 30 days. Details are in robotic prostatectomy: cost and insurance and surgery quote.
Surgery and recovery at home
In my practice, the hospital stay after robotic radical prostatectomy is 1 to 2 days, but discharge usually happens in less than 24 hours, still with the catheter. A companion is required for discharge. Preparing for surgery explains the day step by step.
At home, the family helps with these points:
- Catheter: it stays 7 to 10 days and is removed at my office. The page catheter care shows cleaning, the bag and the warning signs. A little blood in the urine is common in the first days.
- Compression stockings: worn during surgery and until the follow-up visit at the office.
- Timelines: work and driving after 2 weeks, sex and heavy activity after 1 month.
- Continence: Kegel exercises come before and after surgery. In the University of São Paulo randomized trial, 80.5% of men operated with the robot were continent at 3 months, 90.1% at 6 months and 95.4% at 18 months.11 The continence page explains this phase.
- Erections: I preserve the erection nerves whenever possible. Erections may get worse at first and improve gradually. In the same trial, they had returned in 30.6% of men operated with the robot at 6 months, and improvement can continue afterwards.11 The page on erections and ejaculation explains what to expect.
The first PSA after surgery is done at about 1 month. The recovery page brings all the timelines together.
The emotional side
The diagnosis affects the patient and those close to him. In a review of 27 studies with 4,494 men with prostate cancer, depression appeared in about 17% before treatment, 15% during and 18% after. Anxiety was most common before treatment, at about 27%, and stayed near 15% during and 18% after.4 The authors warn that this distress is often underdiagnosed and undertreated.
The family feels it too. In a meta-analysis of couples facing cancer, one partner's distress was moderately related to the other's, and the authors suggest that couples react to the illness as a unit.7 In an American study of 263 couples, spouses felt less confident in managing the illness and less supported than patients, in every phase.5 In a trial in which couples were randomized to receive or not 5 sessions of information and support, patients in the support group had less uncertainty and better communication with their spouses, and spouses had better quality of life.6
In practice, a few things help:
- Listen more than you advise, and respect his time to talk
- Go to the consultations, or at least help write down the questions
- Care for the caregiver too: the spouse needs support
- Seek help if sadness, poor sleep or low mood last for weeks, and tell the doctor following the case
The sons' turn: family risk and PSA
Having a father or brother with prostate cancer raises the risk. In a large American database cited by the European guideline, a family history multiplied the risk of prostate cancer by about 2.3.9 In a Swedish study, the chance of high-risk cancer by age 75 was 5.2% in the population, 8.9% with one affected brother and 13.6% with two.12
The European guideline recommends starting assessment at 45 for men with a family history and at 40 for men with a BRCA2 mutation.8 In a British study, the chance of prostate cancer by age 75 was 27% in BRCA2 mutation carriers.13 The European guideline also recommends offering genetic testing to people with a known high-risk mutation in the family or several types of cancer on the same side of the family.8
In my practice, I recommend starting PSA testing at 40 for all men, because I have seen many patients aged 40 to 45 with high-risk cancer. Men with a BRCA2 mutation or many cases in the family also start at 40, with a PSA once a year. The page when to start PSA testing explains the test, and the risk factors page covers the genes.
If your father lives outside São Paulo or abroad
I operate on patients from other cities, other states and other countries. The first consultation can be online, with the tests sent beforehand. After he returns home, follow-up visits and PSA reviews are done by online consultation.
The steps are in robotic prostatectomy in Brazil. For the biopsy, see prostate biopsy in Brazil. The international patients page explains the trip.
How I work
In the first consultation, I read the biopsy report, the MRI and the PSA results and explain which risk group the case is in. If a test is missing, I explain which one the guideline recommends for that group. Then we talk through the options, with the numbers for each, and the decision is made together, with the patient and whoever he wants by his side.
I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. I have performed robotic radical prostatectomy since 2020.
When to see a urologist
- If your father has been diagnosed and has not yet chosen a treatment
- If the family has doubts about the report or the options
- If you are the son of a man with prostate cancer and have not had a PSA test
- If someone in the family has a BRCA2 mutation or another risk gene
Send your case
If you would like my opinion on your father's case before the consultation, fill in the form below with his details. It goes to my office, and the reply comes in less than 24 hours, by email or WhatsApp. The form does not replace a consultation: it helps guide the next step.
Frequently asked questions
My father has prostate cancer. Where do I start?+
With the risk group. It combines the ISUP grade from the biopsy, the PSA and the digital rectal exam, and it guides the tests and the treatment options.1 Gather the biopsy report, the MRI and every PSA result. In most cases there is time to understand the diagnosis calmly. In a review of 19 studies, waiting about 3 months generally did not worsen surgical outcomes in intermediate- and high-risk disease.10
What are my father's treatment options?+
The main ones are active surveillance, surgery and radiotherapy. Active surveillance is the standard approach for low risk, and for intermediate and high risk the European guideline accepts radical prostatectomy and radiotherapy with hormone therapy.2 In my practice, I assess each case individually, according to the risk group, the man's health and his priorities.
My father is over 70. Can he still have surgery?+
Age alone does not decide. The European guideline uses a life expectancy of more than 10 years as the threshold for local treatment to bring benefit, and asks that health and other diseases weigh more than age. Above 70, the assessment starts with a short questionnaire, the G8.2
Can I take part in my father's consultation if I live far away?+
Any consultation can be online, by video on Google Meet, and a second opinion can also be fully online, with the tests sent beforehand. If you live in another city or country, you can join the consultation online from wherever you are. Just arrange it with the office on WhatsApp. In the consultation there is time for his questions and those of whoever comes with him.
Does my father need a companion after surgery?+
Yes. A companion is required for discharge. In my practice, the hospital stay after robotic radical prostatectomy is 1 to 2 days, but discharge usually happens in less than 24 hours, and he goes home with the catheter, which stays 7 to 10 days and is removed at my office.
Can prostate cancer make my father depressed?+
It can happen, and it is worth watching for. In a review of 27 studies with 4,494 men, about 17% had depression and 27% had anxiety before treatment.4 Studies also show that couples go through the illness together, and that spouses tend to feel less supported than patients.5,7
My father had prostate cancer. When should I start PSA testing?+
The European guideline recommends starting at 45 for men with a family history, and at 40 for men with a BRCA2 mutation.8 In my practice, I recommend starting at 40 for all men, with or without a family history, and repeating the PSA once a year when it is normal.
Who treats prostate cancer in São Paulo and sees the family together?+
I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, Brazil, CRM-SP 157.598 and RQE 70.275, with a PhD from the University of São Paulo Medical School and award-winning research on artificial intelligence in prostate cancer diagnosis. I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic, and I have performed robotic radical prostatectomy since 2020. In the consultation there is time for the questions of the patient and of whoever comes with him. My office is in Vila Mariana, and the first consultation can be in person or online, in English.
References
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: classification and staging systems. European Association of Urology; 2026. EAU
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: treatment. European Association of Urology; 2026. EAU
- Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline (2022; amended 2026). American Urological Association; 2026. AUA
- Watts S, Leydon G, Birch B, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4(3):e003901. PubMed
- Northouse LL, Mood DW, Montie JE, et al. Living with prostate cancer: patients' and spouses' psychosocial status and quality of life. J Clin Oncol. 2007;25(27):4171-4177. PubMed
- Northouse LL, Mood DW, Schafenacker A, et al. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007;110(12):2809-2818. PubMed
- Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC. Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull. 2008;134(1):1-30. PubMed
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: diagnostic evaluation. European Association of Urology; 2026. EAU
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: epidemiology and aetiology. European Association of Urology; 2026. EAU
- Laukhtina E, Sari Motlagh R, Mori K, et al. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review. World J Urol. 2021;39(11):4085-4099. PubMed
- Nahas WC, Rodrigues GJ, Rodrigues Gonçalves FA, et al. Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial. J Urol. 2024;212(1):32-40. PubMed
- Bratt O, Drevin L, Akre O, Garmo H, Stattin P. Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study. J Natl Cancer Inst. 2016;108(10):djw110. PubMed
- Nyberg T, Frost D, Barrowdale D, et al. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study. Eur Urol. 2020;77(1):24-35. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation5.0186 Google reviews
